Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI problems as a result of inhibition of the synthesis of gastroprotective brokers for example PGE2 and also other prostaglandins. This inhibition leads to decreased mucin creation by gastric epithelial cells, significantly less bicarbonate secretion, and less epithelial mobile turnover, https://asenacax864sak2.ouyawiki.com/user